Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)
Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –
Alvotech total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Alvotech's total debt was $1.31B at Jun 30, 2026. For fiscal 2025 it was $1.30B, up 21.6% from the year before. The highest annual figure on record is $1.30B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | +21.6% |
| FY2024 | Dec 31, 2024 | $1.07B | +11.3% |
| FY2023 | Dec 31, 2023 | $960.16M | +22.4% |
| FY2022 | Dec 31, 2022 | $784.49M | +95.7% |
| FY2021 | Dec 31, 2021 | $400.91M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.31B | +23.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.30B | +35.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.12B | +42.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.07B | +36.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.06B | +163.4% |
| Q4 FY2023 | Dec 31, 2023 | $960.16M | – |
| Q2 FY2023 | Jun 30, 2023 | $786.18M | – |
| Q4 FY2022 | Dec 31, 2022 | $784.49M | – |
| Q4 FY2021 | Dec 31, 2021 | $400.91M | – |
See a number that looks wrong?